Google DeepMind's Isomorphic Labs is set to begin human trials of drugs designed by artificial intelligence, marking a ...

Mind the ever-present risks: Of course, we should not get complacent. There will always be risks to worry about, such as U.S.

Google DeepMind's Isomorphic Labs is preparing for human trials of AI-designed drugs, marking a significant advancement in ...

A waste management tracking system developed by four students from Holy Angel University in Angeles, Pampanga won the ...

Open VSX, a popular third-party extension marketplace for AI-powered code editors like Cursor and Windsurf, was found to ...

The iPhone seemed to have the most issues with this concept. While the goblin is certainly monstrous, it's neither creepy nor ...

One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...

Celestica's strong product portfolio targets $29 billion AI switching market by FY29. Click here to read more on CLS stock ...

More tech workers feel the pain as Microsoft pivots. Suddenly, the world's most valuable company is going on without them.

An alarming new trend has emerged in the world of management: bosses using AI to decide who to promote, who to discipline, ...

TipRanks’ analyst ranking service highlights three stocks, including Dell Technologies and Amazon, favored by Wall Street’s ...

Microsoft and Nvidia race to $4T, but Microsoft's AI strategy faces huge risks from its OpenAI feud, chip delays, and rising ...